| Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray CP Hans, DD Weisenburger, TC Greiner, RD Gascoyne, J Delabie, G Ott, ... Blood 103 (1), 275-282, 2004 | 4942 | 2004 |
| A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy WWL Choi, DD Weisenburger, TC Greiner, MA Piris, AH Banham, ... Clinical cancer research 15 (17), 5494-5502, 2009 | 851 | 2009 |
| Cyclin D1–negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling K Fu, DD Weisenburger, TC Greiner, S Dave, G Wright, A Rosenwald, ... Blood 106 (13), 4315-4321, 2005 | 663 | 2005 |
| Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab PN Meyer, K Fu, TC Greiner, LM Smith, J Delabie, RD Gascoyne, G Ott, ... Journal of clinical oncology 29 (2), 200-207, 2011 | 609 | 2011 |
| Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma J Iqbal, G Wright, C Wang, A Rosenwald, RD Gascoyne, ... Blood, The Journal of the American Society of Hematology 123 (19), 2915-2923, 2014 | 523 | 2014 |
| Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma J Iqbal, DD Weisenburger, TC Greiner, JM Vose, T McKeithan, C Kucuk, ... Blood, The Journal of the American Society of Hematology 115 (5), 1026-1036, 2010 | 421 | 2010 |
| Dose response to vitamin D supplementation in postmenopausal women: a randomized trial JC Gallagher, A Sai, T Templin, L Smith Annals of internal medicine 156 (6), 425-437, 2012 | 420 | 2012 |
| Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell–like and non–germinal center B-cell–like subtypes of diffuse large B … K Fu, DD Weisenburger, WWL Choi, KD Perry, LM Smith, X Shi, CP Hans, ... Journal of Clinical Oncology 26 (28), 4587-4594, 2008 | 403 | 2008 |
| Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies A Munden, R Butschek, WL Tom, JS Marshall, DM Poeltler, SE Krohne, ... British Journal of Dermatology 170 (4), 907-913, 2014 | 334 | 2014 |
| Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma J Iqbal, TC Greiner, K Patel, BJ Dave, L Smith, J Ji, G Wright, WG Sanger, ... Leukemia 21 (11), 2332-2343, 2007 | 283 | 2007 |
| The effect of vitamin D supplementation on serum 25OHD in thin and obese women JC Gallagher, V Yalamanchili, LM Smith The Journal of steroid biochemistry and molecular biology 136, 195-200, 2013 | 240 | 2013 |
| MYC and BCL 2 protein expression predicts survival in patients with diffuse large B‐cell lymphoma treated with rituximab AM Perry, Y Alvarado‐Bernal, JA Laurini, LM Smith, GW Slack, KL Tan, ... British journal of haematology 165 (3), 382-391, 2014 | 238 | 2014 |
| IDH2 R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma C Wang, TW McKeithan, Q Gong, W Zhang, A Bouska, A Rosenwald, ... Blood, The Journal of the American Society of Hematology 126 (15), 1741-1752, 2015 | 235 | 2015 |
| BCL2 predicts survival in germinal center B-cell–like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab J Iqbal, PN Meyer, LM Smith, NA Johnson, JM Vose, TC Greiner, ... Clinical Cancer Research 17 (24), 7785-7795, 2011 | 214 | 2011 |
| Effects of thymoquinone in the expression of mucin 4 in pancreatic cancer cells: implications for the development of novel cancer therapies MP Torres, MP Ponnusamy, S Chakraborty, LM Smith, S Das, HA Arafat, ... Molecular cancer therapeutics 9 (5), 1419-1431, 2010 | 193 | 2010 |
| Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125) SC Chauhan, AP Singh, F Ruiz, SL Johansson, M Jain, LM Smith, ... Modern Pathology 19 (10), 1386-1394, 2006 | 188 | 2006 |
| Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma TC Greiner, C Dasgupta, VV Ho, DD Weisenburger, LM Smith, JC Lynch, ... Proceedings of the National Academy of Sciences 103 (7), 2352-2357, 2006 | 185 | 2006 |
| Low-dose chemotherapy and rituximab for posttransplant lymphoproliferative disease (PTLD): a Children’s Oncology Group Report TG Gross, MA Orjuela, SL Perkins, JR Park, JC Lynch, MS Cairo, ... American Journal of Transplantation 12 (11), 3069-3075, 2012 | 175 | 2012 |
| Medium doses of daily vitamin D decrease falls and higher doses of daily vitamin D3 increase falls: a randomized clinical trial LM Smith, JC Gallagher, C Suiter The Journal of steroid biochemistry and molecular biology 173, 317-322, 2017 | 174 | 2017 |
| Morbidity and mortality rates following cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy compared with other high-risk surgical oncology procedures JM Foster, R Sleightholm, A Patel, V Shostrom, B Hall, B Neilsen, ... JAMA network open 2 (1), e186847-e186847, 2019 | 173 | 2019 |
Randy D GascoyneProfessor of Pathology, University of British Columbia在 bccancer.bc.ca 的电子邮件经过验证
